Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about 89bio aggregated by PharmaCompass.com.

    Client Virtual Booth

    89BIO

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    89bio
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    142 Sansome Street, 2nd Floor San Francisco CA 94104
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.89bio.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
    89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors

    https://www.globenewswire.com/news-release/2024/04/17/2864947/0/en/89bio-Appoints-Biotech-Industry-Veteran-Martin-Babler-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    17 Apr 2024
    Share Share
    89bio lines up BiBo Pharma to build $135M commercial API plant
    89bio lines up BiBo Pharma to build $135M commercial API plant

    https://www.fiercepharma.com/manufacturing/89bio-lines-china-cdmo-build-api-plant-commercial-production-mash-candidate

    Kevin Dunleavy FIERCE PHARMA
    11 Apr 2024
    Share Share
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/04/05/2858731/0/en/89bio-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Apr 2024
    Share Share
    89bio wins EMA priority status for MASH candidate pegozafermin
    89bio wins EMA priority status for MASH candidate pegozafermin

    https://www.pharmaceutical-technology.com/news/89bio-wins-ema-priority-status-for-mash-candidate-pegozafermin/

    Robert Barrie PHARMACEUTICAL TECHNOLOGY
    27 Mar 2024
    Share Share
    89bio Receives EMA Status for Pegozafermin in the Treatment of MASH
    89bio Receives EMA Status for Pegozafermin in the Treatment of MASH

    https://www.globenewswire.com/news-release/2024/03/27/2853082/0/en/89bio-Receives-EMA-PRIME-Status-for-Pegozafermin-in-the-Treatment-of-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH-with-Fibrosis-and-Compensated-Cirrhosis.html

    GLOBENEWSWIRE
    27 Mar 2024
    Share Share
    89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin
    89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin

    https://www.globenewswire.com//news-release/2024/03/12/2844476/0/en/89bio-Initiates-Phase-3-ENLIGHTEN-Fibrosis-Trial-of-Pegozafermin-in-Non-Cirrhotic-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH-Patients-with-Fibrosis.html

    GLOBENEWSWIRE
    12 Mar 2024
    Share Share
    89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/03/08/2843322/0/en/89bio-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    08 Mar 2024
    Share Share
    89bio to Participate in the Leerink Partners Global Biopharma Conference
    89bio to Participate in the Leerink Partners Global Biopharma Conference

    https://www.globenewswire.com//news-release/2024/03/05/2840888/0/en/89bio-to-Participate-in-the-Leerink-Partners-Global-Biopharma-Conference.html

    GLOBENEWSWIRE
    05 Mar 2024
    Share Share
    89bio Reports Fourth Quarter and Full Year 2023 Financial Results
    89bio Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/02/29/2838404/0/en/89bio-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Updates.html

    GLOBENEWSWIRE
    29 Feb 2024
    Share Share
    89bio to Participate in the Oppenheimer 34th Annual Life Sciences Conference
    89bio to Participate in the Oppenheimer 34th Annual Life Sciences Conference

    https://www.globenewswire.com//news-release/2024/02/06/2824708/0/en/89bio-to-Participate-in-the-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html

    GLOBENEWSWIRE
    06 Feb 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search